Eldar Mordechay Cegla - 04 Aug 2026 Form 4 Insider Report for Innoviz Technologies Ltd. (INVZ)

Reporting relationship: Chief Financial Officer
Issuer ticker: INVZ
Reported as of: 04 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Aug 2026, 16:19:06 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Dafna Raz - Attorney-in-Fact

Key filing fact

Eldar Mordechay Cegla filed Form 4 for Innoviz Technologies Ltd. (INVZ) on 05 Aug 2026.

Key facts

This page summarizes Eldar Mordechay Cegla's Form 4 filing for Innoviz Technologies Ltd. (INVZ).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2026, 16:19.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001964080 Primary reporting owner

Cegla Eldar Mordechay

Relationship: Chief Financial Officer
Address: C/O INNOVIZ TECHNOLOGIES LTD., 5 URI ARIAV STREET, BUILDING C, ROSH HA'AIN, ISRAEL
Signature: /s/ Dafna Raz - Attorney-in-Fact
Signature date: 05 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INVZ transaction

Ordinary Shares

Award

Transaction value
Shares: +73,184
Change %: +16%
Price: $0.000000^*
Shares after: 537,237
Date: 04 Aug 2026
Ownership: Direct
Footnotes: F1, F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INVZ transaction Derivative

Share Option

Award

Transaction value
Shares: +78,416
Change %
Price: $0.000000^*
Shares after: 78,416
Date: 04 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 78,416
Exercise price: $0.4200
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents 73,184 Restricted Share Units (RSUs) granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on the vesting date. Each RSU represents a contingent right to receive one ordinary share. No exercise price is applicable.

Footnote F2

Includes 234,628 ordinary shares issuable upon vesting of RSUs; of which (a) 2,607 RSUs granted August 9, 2022, vesting quarterly through 2026; (b) 11,104 RSUs granted August 1, 2023, vesting quarterly through 2027; (c) 13,109 RSUs granted February 27, 2024, with 2,616 vesting quarterly through 2027 and 10,493 vesting quarterly through 2028; (d) 25,524 RSUs granted August 20, 2024, vesting quarterly through 2028; (e) 15,092 RSUs granted February 25, 2025, vesting quarterly through 2029; (f) 41,016 RSUs granted August 5, 2025, vesting quarterly through 2029; (g) 52,992 RSUs granted November 11, 2025, one-fourth vesting on November 11, 2026, remainder vesting quarterly through 2029; and (h) 73,184 RSUs granted August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030.

Footnote F3

Vesting is subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date. Each RSU represents a contingent right to receive one ordinary share.

Footnote F4

Share options granted on August 4, 2026, one-fourth vesting on August 4, 2027, remainder vesting quarterly through 2030, subject to the Reporting Person remaining a service provider of the Issuer on each applicable vesting date.